Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» priority review
priority review
AstraZeneca nabs priority review voucher as Wellstat bags FDA OK
Fierce Biotech
Tue, 09/8/15 - 08:21 am
AstraZeneca
FDA
Wellstat
priority review
review vouchers
Xuriden
Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use
Fierce Pharma Marketing
Wed, 09/2/15 - 10:16 am
Opdivo
Bristol-Myers Squibb
FDA
priority review
non-small cell lung cancer
Will Bristol-Myers (BMY) Stock Be Helped by Myeloma Gaining FDA Priority Review Approval?
TheStreet.com
Tue, 09/1/15 - 06:46 pm
Bristol-Myers Squibb
priority review
FDA
Multiple Myeloma
Empliciti
FDA Grants Priority Review for Intercept's Obeticholic Acid for the Treatment of Primary Biliary Cirrhosis
Yahoo
Mon, 08/31/15 - 08:26 am
FDA
Intercept Pharma
obeticholic acid
priority review
primary biliary cirrhosis
Sarepta snags priority review status to keep pace with BioMarin in DMD race
Fierce Biotech
Wed, 08/26/15 - 09:28 am
Sarepta Therapeutics
priority review
Duchenne Muscular Dystrophy
FDA
eteplirsen
drisapersen
Biomarin
Sarepta, Biomarin vie for DMD approval, priority review voucher
BioPharma Dive
Mon, 08/24/15 - 11:47 am
Sarepta
Biomarin
Duchenne Muscular Dystrophy
FDA
priority review
review vouchers
Why Four Months Is Worth $350m To AbbVie And Filgotinib
Seeking Alpha
Fri, 08/21/15 - 05:19 pm
AbbVie
filgotinib
FDA
review vouchers
priority review
Did AbbVie Just Make an Incredibly Brilliant Decision?
Motley Fool
Fri, 08/21/15 - 09:31 am
AbbVie
priority review
review vouchers
United Therapeutics
AbbVie Inc May Use Priority Voucher To Gain Lymphoma Lead Over Roche
Bidness, ETC
Thu, 08/20/15 - 11:53 am
AbbVie
priority review
Roche
CLL
chronic lymphocytic leukemia
United Therapeutics
AbbVie buys special review voucher for $350 mln
Yahoo/Reuters
Wed, 08/19/15 - 12:25 pm
AbbVie
priority review
review vouchers
United Therapeutics
Speedy US review for J&J sarcoma drug Yondelis
Pharma Times
Tue, 02/3/15 - 11:31 am
JNJ
sarcoma
Yondelis
priority review
Zeltia
Drug Industry’s VIP Pass Costs $125 Million and Climbing
Bloomberg
Tue, 01/6/15 - 09:11 am
priority review
FDA
Knight Therapeutics
Impavido
Go-go execs at Gilead nab an FDA priority review voucher for $125M
Fierce Biotech
Wed, 11/19/14 - 08:53 am
FDA
Gilead Sciences
priority review
Pages
« first
‹ previous
1
2
3
4
5
6